AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Mashiba, T Burr, DB Turner, CH Sato, M Cain, RL Hock, JM
Citation: T. Mashiba et al., Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits, BONE, 28(5), 2001, pp. 538-547

Authors: Jerome, CP Burr, DB Van Bibber, T Hock, JM Brommage, R
Citation: Cp. Jerome et al., Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomizedcynomolgus monkeys (Macaca fascicularis), BONE, 28(2), 2001, pp. 150-159

Authors: Hock, JM Krishnan, V Onyia, JE Bidwell, JP Milas, J Stanislaus, D
Citation: Jm. Hock et al., Osteoblast apoptosis and bone turnover, J BONE MIN, 16(6), 2001, pp. 975-984

Authors: Burr, DB Hirano, T Turner, CH Hotchkiss, C Brommage, R Hock, JM
Citation: Db. Burr et al., Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys, J BONE MIN, 16(1), 2001, pp. 157-165

Authors: Stanislaus, D Devanarayan, V Hock, JM
Citation: D. Stanislaus et al., In vivo comparison of activated protein-1 gene activation in response to human parathyroid hormone (hPTH)(1-34) and hPTH(1-84) in the distal femur metaphyses of young mice, BONE, 27(6), 2000, pp. 819-826

Authors: Hock, JM
Citation: Jm. Hock, Discrimination among osteoblasts? Parathyroid hormone analog may reveal site-specific differences in mice, BONE, 27(4), 2000, pp. 467-469

Authors: Stanislaus, D Yang, X Liang, JD Wolfe, J Cain, RL Onyia, JE Falla, N Marder, P Bidwell, JP Queener, SW Hock, JM
Citation: D. Stanislaus et al., In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment, BONE, 27(2), 2000, pp. 209-218

Authors: Feister, HA Onyia, JE Miles, RR Yang, X Galvin, R Hock, JM Bidwell, JP
Citation: Ha. Feister et al., The expression of the nuclear matrix proteins NuMA, topoisomerase II-alpha, and -beta in bone and osseous cell culture: Regulation by parathyroid hormone, BONE, 26(3), 2000, pp. 227-234

Authors: Stewart, AF Cain, RL Burr, DB Jacob, D Turner, CH Hock, JM
Citation: Af. Stewart et al., Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhancesbone mass and biomechanical properties: A comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroidhormone 893, J BONE MIN, 15(8), 2000, pp. 1517-1525

Authors: Frolik, CA Chandrasekhar, S Tashjian, AH Hock, JM
Citation: Ca. Frolik et al., Further data are required to assure that the discrepant binding affinity is explained by different receptor conformations, J BONE MIN, 15(3), 2000, pp. 608-608

Authors: Hirano, T Burr, DB Cain, RL Hock, JM
Citation: T. Hirano et al., Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34), CALCIF TIS, 66(6), 2000, pp. 456-460

Authors: Miles, RR Sluka, JP Halladay, DL Santerre, RF Hale, LV Bloem, L Thirunavukkarasu, K Galvin, RJS Hock, JM Onyia, JE
Citation: Rr. Miles et al., ADAMTS-1: A cellular disintegrin and metalloprotease with thrombospondin motifs is a target for parathyroid hormone in bone, ENDOCRINOL, 141(12), 2000, pp. 4533-4542

Authors: Miles, RR Sluka, JP Santerre, RF Hale, LV Bloem, L Boguslawski, G Thirunavukkarasu, K Hock, JM Onyia, JE
Citation: Rr. Miles et al., Dynamic regulation of RGS2 in bone: Potential new insights into parathyroid hormone signaling mechanisms, ENDOCRINOL, 141(1), 2000, pp. 28-36

Authors: Hirano, T Burr, DB Turner, CH Sato, M Cain, RL Hock, JM
Citation: T. Hirano et al., Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits, J BONE MIN, 14(4), 1999, pp. 536-545

Authors: Frolik, CA Cain, RL Sato, M Harvey, AK Chandrasekhar, S Black, EC Tashjian, AH Hock, JM
Citation: Ca. Frolik et al., Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-Related protein (1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in rats, J BONE MIN, 14(2), 1999, pp. 163-172

Authors: Liang, JD Hock, JM Sandusky, GE Santerre, RF Onyia, JE
Citation: Jd. Liang et al., Immunohistochemical localization of selected early response genes expressed in trabecular bone of young rats given hPTH 1-34, CALCIF TIS, 65(5), 1999, pp. 369-373

Authors: Onyia, JE Hale, LV Miles, RR Cain, RL Tu, Y Hulman, JF Hock, JM Santerre, RF
Citation: Je. Onyia et al., Molecular characterization of gene expression changes in ROS 17/2.8 cells cultured in diffusion chambers in vivo, CALCIF TIS, 65(2), 1999, pp. 133-138

Authors: Hock, JM
Citation: Jm. Hock, Stemming bone loss by suppressing apoptosis, J CLIN INV, 104(4), 1999, pp. 371-373

Authors: Brommage, R Hotchkiss, CE Lees, CJ Stancill, MW Hock, JM Jerome, CP
Citation: R. Brommage et al., Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys, J CLIN END, 84(10), 1999, pp. 3757-3763
Risultati: 1-19 |